Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia? [PDF]
Lloyd Z, Roxburgh A.
europepmc +1 more source
Exploring risk tolerance among individuals who use opioids. [PDF]
Lothumalla S +10 more
europepmc +1 more source
Not a Disease of the Past: A Case Report of Heroin-Induced Toxic Leukoencephalopathy Causing Progressive Neurologic Decline. [PDF]
Chabalout MN +3 more
europepmc +1 more source
Association between the location of Opioid Agonist Treatment (OAT) providers and heroin-related ambulance attendances. [PDF]
Hall N +5 more
europepmc +1 more source
Methamphetamine Use and Psychiatric Morbidity in Sri Lanka: Sociodemographic Insights from a Tertiary Care Clinic. [PDF]
Galhenage J +3 more
europepmc +1 more source
Early onset of cannabis use and risk for opioid use disorder across two decades in the United States. [PDF]
Agrawal A, Nelson EC.
europepmc +1 more source
Non-fatal drug overdose surveillance using hospital discharge data: a comparison between the Drug Overdose Surveillance and Epidemiology (DOSE) system and the Healthcare Cost and Utilisation Project, 18 states, 2018-2020. [PDF]
Quader ZS +4 more
europepmc +1 more source
Differences in anxiety, depression, and heart rate variability between patients with methamphetamine use disorder and heroin use disorder patients on methadone maintenance treatment. [PDF]
Kong S, Mo G, Wan J, Ren Z.
europepmc +1 more source
FAAH rs324420 Polymorphism in People With Opioid and Methamphetamine Use Disorders: Psychological Associations. [PDF]
Erekli-Arat Ö +4 more
europepmc +1 more source

